Answers are grounded in this paper and cite their sources.
The review is devoted to the analysis of the modern conceptions about role of specific regulatory protein HIF-1α (hypoxia-inducible factor-1alpha) in the mechanisms of adaptation to hypoxia. Experimental and clinical results of using of different HIF-1α inducers (inhibitors of HIF-1α degradation and inactivation, activators of transcription and translation of HIF-1α) to activate the processes of immediate and delayed organism adaptation to hypoxia is discussed in the article. This approach opens promising opportunities for effective pharmacotherapy of cardiovascular and other diseases with hypoxia and ischemia in their pathogenesis.
No takes yet. Share an insight, caveat, or question.
Левченкова et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: